News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
704,621 Results
Type
Article (43215)
Company Profile (275)
Press Release (661131)
Section
Business (205479)
Career Advice (2028)
Deals (35554)
Drug Delivery (96)
Drug Development (81630)
Employer Resources (173)
FDA (16256)
Job Trends (14946)
News (347315)
Policy (32766)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (5)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2632)
Accelerated approval (6)
Adcomms (23)
Allergies (82)
Alliances (49868)
ALS (88)
Alzheimer's disease (1371)
Antibody-drug conjugate (ADC) (113)
Approvals (16252)
Artificial intelligence (239)
Autoimmune disease (18)
Automation (14)
Bankruptcy (363)
Best Places to Work (11727)
BIOSECURE Act (19)
Biosimilars (102)
Biotechnology (200)
Bladder cancer (60)
Brain cancer (27)
Breast cancer (256)
Cancer (2055)
Cardiovascular disease (165)
Career advice (1690)
Career pathing (29)
CAR-T (144)
Cell therapy (407)
Cervical cancer (19)
Clinical research (66164)
Collaboration (791)
Compensation (488)
Complete response letters (21)
COVID-19 (2620)
CRISPR (39)
C-suite (222)
Cystic fibrosis (100)
Data (2032)
Decentralized trials (2)
Denatured (16)
Depression (40)
Diabetes (251)
Diagnostics (6416)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (118)
Drug pricing (97)
Drug shortages (25)
Duchenne muscular dystrophy (89)
Earnings (86542)
Editorial (32)
Employer branding (21)
Employer resources (147)
Events (112719)
Executive appointments (668)
FDA (17402)
Featured Employer (50)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (709)
Gene editing (104)
Generative AI (21)
Gene therapy (297)
GLP-1 (697)
Government (4426)
Grass and pollen (5)
Guidances (49)
Healthcare (18940)
Huntington's disease (22)
IgA nephropathy (24)
Immunology and inflammation (105)
Indications (26)
Infectious disease (2757)
Inflammatory bowel disease (133)
Inflation Reduction Act (8)
Influenza (49)
Intellectual property (88)
Interviews (317)
IPO (16554)
IRA (40)
Job creations (3653)
Job search strategy (1437)
Kidney cancer (9)
Labor market (34)
Layoffs (464)
Leadership (16)
Legal (7959)
Liver cancer (72)
Lung cancer (301)
Lymphoma (137)
Machine learning (4)
Management (58)
Manufacturing (274)
MASH (63)
Medical device (13351)
Medtech (13356)
Mergers & acquisitions (19490)
Metabolic disorders (648)
Multiple sclerosis (72)
NASH (16)
Neurodegenerative disease (84)
Neuropsychiatric disorders (25)
Neuroscience (1875)
NextGen: Class of 2025 (6584)
Non-profit (4544)
Northern California (2493)
Now hiring (37)
Obesity (349)
Opinion (208)
Ovarian cancer (73)
Pain (81)
Pancreatic cancer (78)
Parkinson's disease (143)
Partnered (20)
Patents (211)
Patient recruitment (99)
Peanut (46)
People (57584)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20665)
Phase II (29119)
Phase III (21698)
Pipeline (1084)
Podcasts (47)
Policy (117)
Postmarket research (2584)
Preclinical (8788)
Press Release (67)
Prostate cancer (95)
Psychedelics (31)
Radiopharmaceuticals (245)
Rare diseases (380)
Real estate (5945)
Recruiting (65)
Regulatory (22359)
Reports (46)
Research institute (2421)
Resumes & cover letters (354)
Rett syndrome (4)
RNA editing (4)
RSV (39)
Schizophrenia (66)
Series A (126)
Series B (80)
Service/supplier (12)
Sickle cell disease (54)
Southern California (2154)
Special edition (15)
Spinal muscular atrophy (158)
Sponsored (28)
Startups (3625)
State (2)
Stomach cancer (13)
Supply chain (62)
Tariffs (15)
The Weekly (29)
United States (21723)
Vaccines (674)
Venture capitalists (37)
Webinars (12)
Weight loss (228)
Women's health (33)
Worklife (15)
Date
Today (113)
Last 7 days (496)
Last 30 days (2569)
Last 365 days (33447)
2025 (8666)
2024 (35485)
2023 (40328)
2022 (51535)
2021 (56046)
2020 (54405)
2019 (46880)
2018 (35319)
2017 (32459)
2016 (31930)
2015 (37930)
2014 (31655)
2013 (26843)
2012 (29023)
2011 (29673)
2010 (27747)
Location
Africa (743)
Alabama (51)
Alaska (7)
Arizona (228)
Arkansas (13)
Asia (38232)
Australia (6295)
California (5684)
Canada (1903)
China (480)
Colorado (249)
Connecticut (266)
Delaware (130)
Europe (82558)
Florida (844)
Georgia (198)
Idaho (57)
Illinois (505)
India (24)
Indiana (296)
Iowa (9)
Japan (147)
Kansas (102)
Kentucky (24)
Louisiana (9)
Maine (62)
Maryland (845)
Massachusetts (4289)
Michigan (214)
Minnesota (376)
Mississippi (2)
Missouri (78)
Montana (27)
Nebraska (25)
Nevada (57)
New Hampshire (63)
New Jersey (1620)
New Mexico (28)
New York (1625)
North Carolina (942)
North Dakota (7)
Northern California (2493)
Ohio (194)
Oklahoma (14)
Oregon (33)
Pennsylvania (1286)
Puerto Rico (9)
Rhode Island (29)
South America (1117)
South Carolina (18)
South Dakota (1)
Southern California (2154)
Tennessee (95)
Texas (845)
Utah (168)
Virginia (133)
Washington D.C. (59)
Washington State (536)
West Virginia (3)
Wisconsin (49)
704,621 Results for "myriad genetics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Myriad Genetics Names Brian Donnelly as New Chief Commercial Officer
April 8, 2025
·
3 min read
Press Releases
Myriad Genetics Announces Senior Leadership Transition
February 25, 2025
·
4 min read
Press Releases
Myriad Genetics and Gabbi to Work Together to Increase Access to Hereditary Cancer Risk Assessment Tools
February 28, 2025
·
3 min read
Press Releases
Myriad Genetics Introduces Online Prenatal Genetic Testing Resource
January 23, 2025
·
4 min read
Genetics in Medicine Publishes Myriad Genetics Patient-Outcomes Study Validating RiskScore® as a Clinical Breast Cancer Risk Assessment Tool
Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that Genetics in Medicine, an official journal of the American College of Medical Genetics and Genomics (ACMG), published a new study validating RiskScore®, Myriad’s breast cancer risk assessment tool integrated into its MyRisk® Hereditary Cancer Test.
June 3, 2024
·
4 min read
Press Releases
MD Anderson and Myriad Genetics form strategic alliance to evaluate clinical utility of Myriad’s molecular residual disease assay
January 8, 2025
·
4 min read
Press Releases
Myriad Genetics Partners with PATHOMIQ to add Artificial Intelligence Technology Platform to its Oncology Portfolio
February 25, 2025
·
6 min read
BioMidwest
Myriad Genetics Launches New Universal Plus Panel for Foresight® Carrier Screen
Myriad Genetics, Inc., a leader in genetic testing and precision medicine, announced the addition of a new Universal Plus Panel to its Foresight® Carrier Screen.
June 4, 2024
·
2 min read
Business
Myriad Genetics Collaborates with GSK to Improve Access to HRD Testing in 9 CountriesNew sponsored testing program leverages Myriad’s MyChoice Tests for patients with high-grade serous ovarian cancer
Myriad Genetics, Inc., a leader in genetic testing and precision medicine, announced a collaboration with GSK aimed at improving access to homologous recombination deficiency diagnostic testing for high-grade serous ovarian cancer patients.
June 11, 2024
·
3 min read
Press Releases
Myriad Genetics to Release Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025
February 19, 2025
·
1 min read
1 of 70,463
Next
